ClinicalTrials.gg

Drug class

Phosphodiesterase Inhibitors clinical trials

A class of medicines: the studies that test any of its 11 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
583
open now
87
in phase 3
81
first study started
1991

Keep track of what changes. Save the phosphodiesterase inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Studies by the year they started

573 studies that test it; most in 2023 (47); 1 more planned to start later

Studies that test Phosphodiesterase Inhibitors, by start year
YearStudies
19911
19953
19961
19971
19982
19994
20005
20015
20029
20036
20045
200511
20069
20076
200811
200920
201021
201122
201223
201329
201422
201519
201625
201719
201821
201936
202029
202120
202231
202347
202435
202540
202635

By phase

A phase 1/2 study counts in both.

Early Phase 1
26
Phase 1
122
Phase 2
148
Phase 3
81
Phase 4
73
No phase
184

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 102 · Other 481

Boehringer Ingelheim (34) · Tanta University (19) · Ain Shams University (13) · Radboud University Medical Center (9) · MediciNova (8) · University of Alcala (6) · University of California, Los Angeles (6) · Beni-Suef University (6)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 583

See all 583 studies that test one of the phosphodiesterase inhibitors →